These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 20074015)

  • 1. A new target for proteasome inhibitors: FoxM1.
    Gartel AL
    Expert Opin Investig Drugs; 2010 Feb; 19(2):235-42. PubMed ID: 20074015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FoxM1 is a general target for proteasome inhibitors.
    Bhat UG; Halasi M; Gartel AL
    PLoS One; 2009 Aug; 4(8):e6593. PubMed ID: 19672316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells.
    Bhat UG; Halasi M; Gartel AL
    PLoS One; 2009; 4(5):e5592. PubMed ID: 19440351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FoxM1 inhibitors as potential anticancer drugs.
    Gartel AL
    Expert Opin Ther Targets; 2008 Jun; 12(6):663-5. PubMed ID: 18479213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Function of Molecular Chaperone HSP70: SUPPRESSION OF ONCOGENIC FOXM1 AFTER PROTEOTOXIC STRESS.
    Halasi M; Váraljai R; Benevolenskaya E; Gartel AL
    J Biol Chem; 2016 Jan; 291(1):142-8. PubMed ID: 26559972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting FOXM1 in cancer.
    Halasi M; Gartel AL
    Biochem Pharmacol; 2013 Mar; 85(5):644-652. PubMed ID: 23103567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor-induced apoptosis but not to autophagy.
    Pandit B; Gartel AL
    Cell Cycle; 2011 Oct; 10(19):3269-73. PubMed ID: 21941087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.
    Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1.
    Radhakrishnan SK; Bhat UG; Hughes DE; Wang IC; Costa RH; Gartel AL
    Cancer Res; 2006 Oct; 66(19):9731-5. PubMed ID: 17018632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
    Wierstra I
    Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of the Oncogenic Transcription Factor FOXM1 by Proteasome Inhibitors.
    Gartel AL
    Scientifica (Cairo); 2014; 2014():596528. PubMed ID: 25093142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micelle-encapsulated thiostrepton as an effective nanomedicine for inhibiting tumor growth and for suppressing FOXM1 in human xenografts.
    Wang M; Gartel AL
    Mol Cancer Ther; 2011 Dec; 10(12):2287-97. PubMed ID: 21903609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of oxidative stress and FOXM1 inhibitors induces apoptosis in cancer cells and inhibits xenograft tumor growth.
    Halasi M; Pandit B; Wang M; Nogueira V; Hay N; Gartel AL
    Am J Pathol; 2013 Jul; 183(1):257-65. PubMed ID: 23665201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome inhibitors suppress expression of NPM and ARF proteins.
    Pandit B; Gartel AL
    Cell Cycle; 2011 Nov; 10(22):3827-9. PubMed ID: 22071628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Siomycin A Induces Apoptosis in Human Lung Adenocarcinoma A549 Cells by Suppressing the Expression of FoxM1.
    Guo X; Liu A; Hua H; Lu H; Zhang D; Lin Y; Sun Q; Zhu X; Yan G; Zhao F
    Nat Prod Commun; 2015 Sep; 10(9):1603-6. PubMed ID: 26594769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression.
    Kwok JM; Myatt SS; Marson CM; Coombes RC; Constantinidou D; Lam EW
    Mol Cancer Ther; 2008 Jul; 7(7):2022-32. PubMed ID: 18645012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mode of FoxM1 regulation: positive auto-regulatory loop.
    Halasi M; Gartel AL
    Cell Cycle; 2009 Jun; 8(12):1966-7. PubMed ID: 19411834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
    Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
    Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico investigation of FOXM1 binding and novel inhibitors in epithelial ovarian cancer.
    Chen Y; Ruben EA; Rajadas J; Teng NNH
    Bioorg Med Chem; 2015 Aug; 23(15):4576-4582. PubMed ID: 26164623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma.
    Uddin S; Hussain AR; Ahmed M; Siddiqui K; Al-Dayel F; Bavi P; Al-Kuraya KS
    Haematologica; 2012 Jul; 97(7):1092-100. PubMed ID: 22271891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.